Robert Mashal insider trades: Nuvation Bio (NUVB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | NUVB | ↑ Buy | 25,000 | $4.73 | $118K | By Trust | Jun 11, 2026 (2d) |
| Apr 1, 2025 | NUVB | ↑ Buy | 100,000 | $1.67 | $167K | By Trust | Apr 3, 2025 (2d) |
| Oct 8, 2024 | NUVB | ↑ Buy | 100,000 | $2.20 | $220K | By Trust | Oct 10, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NUVB insiders
Open-market trades in the last 12 months
About Robert Mashal's insider trades
Robert Mashal is an insider at Nuvation Bio (NUVB). Since Oct 8, 2024, Robert has reported 3 open-market purchases worth $505K and no sales on SEC Form 4. In the last 12 months: 1 buy ($118K).
Their filings also include grants and awards (3 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NUVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.